Vav regulates peptide-specific apoptosis in thymocytes

Journal of Experimental Medicine

Volumn 188, Issue 11, 1998, Pages 2099-2111

  Kong, Young Yun ^a,b   Fischer, Klaus Dieter ^c   Bachmann, Martin F ^d   Mariathasan, Sanjeev ^a,b   Kozieradzki, Ivona ^a,b   Nghiem, Mai P ^a,b   Bouchard, Dennis ^a,b   Bernstein, Alan ^e   Ohashi, Pamela S ^a,b   Penninger, Josef M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Actin cytoskeleton; Negative selection; Protein kinase C; Signaling transduction; Vav

Indexed keywords

CALCIUM ION; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; ONCOPROTEIN; PROTEIN KINASE C; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VAV PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; CELL CYCLE PROTEINS; CYTOKINES; CYTOSKELETON; MICE; MICE, TRANSGENIC; PEPTIDES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031744366     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.11.2099     Document Type: Article

References (83)

1. Collins, T.L., M. Deckert, and A. Altman. 1997. Views on Vav. Immunol. Today. 18:221-225.
2. Bustelo, X.R., J.A. Ledbetter, and M. Barbacid. 1992. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature. 356:68-71.
3. Margolis, B., P. Hu, S. Katzav, W. Li, J.M. Oliver, A. Ullnch, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature. 356:71-74.
4. Katzav, S., D. Martin-Zanca, and M. Barbacid. 1989. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283-2290.
5. Teramoto, H., P. Crespo, O.A. Coso, T. Igishi, N.Z. Xu, and J.S. Gutkind. 1996. The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. J. Biol.Chem. 271:25731-25734.
6. Coso, O.A., M. Chiariello, G. Kalinec, J.M. Kyriakis, J. Woodgett, and J.S. Gutkind. 1995. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270:5620-5624.
7. Tapon, N., and A. Hall. 1997. Rho, Rac and Cdc42 GT-Pases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9:86-92.
8. Minden, A., A. Lin, F.X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 81:1147-1157.
9. Knaus, U.G., S. Morris, H.J. Dong, J. Chernoff, and G.M. Bokoch. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science. 269:221-223.
10. Sells, M.A., U.G. Knaus, S. Bagrodia, D.M. Ambrose, G.M. Bokoch, and J. Chernoff. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210.
11. Gulbins, E., K.M. Coggeshall, C. Langlet, G. Baier, N. Bonnefoyberard, P. Burn, A. Wittinghofer, S. Katzav, and A. Altman. 1994. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol. Cell. Biol. 14:906-913.
12. Gulbins, E., K.M. Coggeshall, G. Baier, S. Katzav, P. Burn, and A. Altman. 1993. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science. 260:822-825.
13. Crespo, P., K.E. Schuebel, A.A. Ostrom, J.S. Gutkind, and X.R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature. 385:169-172.
14. Crespo, P., X.R. Bustelo, D.S. Aaronson, O.A. Coso, M. Lopez-Barahona, M. Barbacid, and J.S. Gutkind. 1996. Rac-1 dependent stimulation of the Jnk/Sapk signaling pathway by Vav. Oncogene. 13:455-460.
15. Han, J.W., B. Das, W. Wei, L. Van Aelst, R.D. Mosteller, R. Khosravi-Far, J.K. Westwick, C.J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346-1353.
16. Fischer, K.D., A. Zmuldzinas, S. Gardner, M. Barbacid, A. Bernstein, and C. Guidos. 1995. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes. Nature. 374:474-477.
17. Tarakhovsky, A., M. Turner, S. Schaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V.L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374:467-470.
18. Zhang, R., F.W. Alt, L. Davidson, S.H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:470-473.
19. Fischer, K.D., Y.Y. Kong, H. Nishina, K. Tedford, L.E.M. Marengere, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, S. Gardener, et al. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554-562.
20. Holsinger, L.J., I.A. Graef, W. Swat, T. Chi, D.M. Bautista, L. Davidson, R.S. Lewis, F.W. Alt, and G.R. Crabtree. 1998. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563-572.
21. Turner, M., P.J. Mee, A.E. Walters, M.E. Quinn, A.L. Mellor, R. Zamoyska, and V.L.J. Tybulewicz. 1997. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity. 7:451-460.
22. Teh, H.S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluethmann, and H. von Boehmer. 1988. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature. 335:229-233.
23. Pircher, H., T.W. Mak, R. Lang, W. Ballhausen, E. Rueedi, H. Hengartner, R.M. Zinkernagel, and K. Buerki. 1989. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J. 8:719-727.
24. von Boehmer, H., H.S. Teh, and P. Kisielow. 1989. The thymus selects the useful, neglects the useless and destroys the harmful. Immunol. Today. 10:57-61.
25. Kisielow, P., H.S. Teh, H. Bluethmann, and H. von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 335:730-733.
26. Sebzda, E., V.A. Wallace, J. Mayer, R.S. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 263:1615-1618.
27. Sebzda, E., T.M. Kuendig, C.T. Thomson, K. Aoki, S.Y. Mak, J.P. Mayer, T. Zamborelli, S.G. Nathenson, and P.S. Ohashi. 1996. Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 183:1093-1104.
28. Harris, W., S.E. Wilkinson, and J.S. Nixon. 1997. Recent developments in protein kinase C inhibitors. Expert Opin. Ther. Patents. 7:63-68.
29. Nishina, H., K.D. Fischer, L. Radvanyi, A. Shahinian, R. Hakem, E.A. Rubie, A. Bernstein, T.W. Mak, J.R. Woodgett, and J.M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 385:350-353.
30. Pircher, H., K. Brduscha, U. Steinhoff, M. Kasai, T. Mizuochi, R.M. Zinkernagel, H. Hengartner, B. Kyewski, and K.P. Mueller. 1993. Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen-presenting cells. Eur. J. Immunol. 23:669-674.
31. Schmid, I., C.H. Uittenbogaart, and J.V. Giorgi. 1994. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry. 15: 12-20.
32. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
33. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch, M.-I. Gomez, M. Castedo, and K. Guido. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.
34. Baeuerle, P.A., and D. Baltimore. 1996. NF-kappa B: ten years after. Cell. 87:13-20.
35. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181:577-584.
36. Penninger, J.M., and G. Kroemer. 1998. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv. Immunol. 68:51-144.
37. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179:709-713.
38. Zamzami, N., P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, and G. Kroemer. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182: 367-377.
39. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129-1132.
40. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147-157.
41. Kluck, R.M., W.-E. Bossy, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
42. Alam, A., M.Y. Braun, F. Hartgers, S. Lesage, L. Cohen, P. Hugo, F. Denis, and R.P. Sekaly. 1997. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J. Exp. Med. 186:1503-1512.
43. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
44. Han, J.W., K. Luby-Phelps, B. Das, X.D. Shu, Y. Xia, R.D. Mosteller, U.M. Krishna, J.R. Falck, M.A. White, and D. Broek. 1998. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 279:558-560.
45. Hofmann, J. 1997. The potential for isoenzyme-selective modulation of protein kinase C. FASEB J. 11:649-669.
46. Baron-Delage, S., and G. Cherqui. 1997. Protein kinase C and tumorigenic potential. Bull. Cancer. 84:829-832.
47. Mochly-Rosen, D., and A.S. Gordon. 1998. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 12:35-42.
48. Baier, G., B.-G. Baier, N. Meller, K.M. Coggeshall, L. Giampa, D. Telford, N. Isakov, and A. Altman. 1994. Expression and biochemical characterization of human protein kinase C-theta. Eur. J. Biochem. 225:195-203.
49. Mischak, H., J. Goodnight, D.W. Henderson, S. Osada, S. Ohno, and J.F. Mushinski. 1993. Unique expression pattern of protein kinase C-theta: high mRNA levels in normal mouse testes and in T-lymphocytic cells and neoplasms. FEBS Lett. 326:51-55.
50. Chang, J.D., Y. Xu, M.K. Raychowdhury, and J.A. Ware. 1993. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J. Biol. Chem. 268:14208-14214.
51. Szamel, M., A. Appel, R. Schwinzer, and K. Resch. 1998. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J. Immunol 160:2207-2214.
52. Baier, B.-G., F. Uberall, B. Bauer, F. Fresser, H. Wachter, H. Grunicke, G. Utermann, A. Altman, and G. Baier. 1996. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell. Biol. 16:1842-1850.
53. Werlen, G., E. Jacinto, Y. Xia, and M. Karin. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17: 3101-3111.
54. Raab, M., A.J. da Silva, P.R. Findell, and C.E. Rudd. 1997. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity. 6:155-164.
55. Tuosto, L., F. Michel, and O. Acuto. 1996. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184:1161-1166.
56. Wu, J., D.G. Motto, G.A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity. 4:593-602.
57. Jacinto, E., G. Werlen, and M. Karin. 1998. Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity. 8:31-41.
58. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol 14:259-274.
59. Arnould, T., E. Kim, L. Tsiokas, F. Jochimsen, W. Gruning, J.D. Chang, and G. Walz. 1998. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 273:6013-6018.
60. Khosravi, F.-R., W.-M. Chrzanowska, P.A. Solski, A. Eva, K. Burridge, and C.J. Der. 1994. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell. Biol. 14:6848-6857.
61. Olson, M.F., N.G. Pasteris, J.L. Gorski, and A. Hall. 1996. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr. Biol. 6:1628-1633.
62. Nishina, H., M. Bachmann, A.J. Oliveira-dos-Santos, I. Kozieradzki, K.D. Fischer, B. Odermatt, A. Wakeham, A. Shahinian, H. Takimoto, A. Bernstein, et al. 1997. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186:941-953.
63. + thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J. Exp. Med. 186: 1911-1922.
64. Kothakota, S., T. Azuma, C. Reinhard, A. Klippel, J. Tang, K.T. Chu, T.J. McGarry, M.W. Kirschner, K. Koths, D.J. Kwiatkowski, and L.T. Williams. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:294-298.
65. Ohtsu, M., N. Sakai, H. Fujita, M. Kashiwagi, S. Gasa, S. Shimizu, Y. Eguchi, Y. Tsujimoto, Y. Sakiyama, K. Kobayashi, and N. Kuzumaki. 1997. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16:4650-4656.
66. Davoodian, K., B.W. Ritchings, R. Ramphal, and M.R. Bubb. 1997. Gelsolin activates DNase I in vitro and in cystic fibrosis sputum. Biochemistry. 36:9637-9641.
67. Brancolini, C., D. Lazarevic, J. Rodriguez, and C. Schneider. 1997. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J. Cell Biol. 139:759-771.
68. Rudel, T., and G.M. Bokoch. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276:1571-1574.
69. Villa, P.G., W.J. Henzel, M. Sensenbrenner, C.E. Henderson, and B. Pettmann. 1998. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J. Cell Sci. 111:713-722.
70. Yang, F.S., X.Y. Sun, W. Beech, B. Teter, S. Wu, J. Sigel, H.V. Vinters, S.A. Frautschy, and G.M. Cole. 1998. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152:379-389.
71. Sakahira, H., M. Enari, and S. Nagata. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:96-99.
72. Donovan, F.M., C.J. Pike, C.W. Cotman, and D.D. Cunningham. 1997. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17:5316-5326.
73. Brown, S.B., K. Bailey, and J. Savill. 1997. Actin is cleaved during constitutive apoptosis. Biochem. J. 323:233-237.
74. Mashima, T., M. Naito, K. Noguchi, D.K. Miller, D.W. Nicholson, and T. Tsuruo. 1997. Actin cleavage by CPP-32/ apopain during the development of apoptosis. Oncogene. 14: 1007-1012.
75. Kayalar, C., T. Ord, M.P. Testa, L.T. Zhong, and D.E. Bredesen. 1996. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA. 93:2234-2238.
76. Brancolini, C., M. Benedetti, and C. Schneider. 1995. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14: 5179-5190.
77. Martin, S.J., G.A. O'Brien, W.K. Nishioka, A.J. McGahon, A. Mahboubi, T.C. Saido, and D.R. Green. 1995. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:6425-6428.
78. Monks, C.R., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-theta during T-cell activation. Nature. 385:83-86.
79. Vasquez, N.J., L.P. Kane, and S.M. Hedrick. 1994. Intracellular signals that mediate thymic negative selection. Immunity. 1:45-56.
80. Nakayama, T., Y. Ueda, H. Yamada, E.W. Shores, A. Singer, and C.H. June. 1992. In vivo calcium elevations in thymocytes with T cell receptors that are specific for self ligands. Science. 257:96-99.
81. Khan, A.A., M.J. Soloski, A.H. Sharp, G. Schilling, D.M. Sabatini, S.H. Li, C.A. Ross, and S.H. Snyder. 1996. Lymphocyte apoptosis: mediation by increased type 3 mositol 1,4,5-trisphosphate receptor. Science. 273:503-507.
82. Jayaraman, T., and A.R. Marks. 1997. Cells deficient in the inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 17:3005-3012.
83. McConkey, D.J., P. Hartzell, P.-J.F. Amador S. Orrenius, and M. Jondal. 1989. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J. Immunol 143:1801-1806.